RxDoctor Payments Data

Alfred Sommer

Ophthalmology · Baltimore, MDNPI 1730392028

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $2,929,268 of the $2,929,310 with a category attached, or 100.0%. BD accounts for 100.0% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2020 at $1,350,774 and has fallen 100.0% since, to $42 in 2025. Among ophthalmology clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,929,310in general payments, 2019–2025

Across 6 payments — averaging $488,218 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • BD$2.9M
  • Johnson & Johnson$42

What the payments were for

  • Speaking & faculty fees$2,929,268100%
  • Food & beverage$420%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
BD5$2,929,268
Johnson & Johnson1$42

How this compares

$2,929,310 in reported general payments places this provider in the 95th percentile of 493 ophthalmology providers in Maryland.

See all ophthalmology providers in Maryland

Other ophthalmology in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →